Singapore Healthcare Analytics Market

Singapore Healthcare Analytics Market Insights Forecasts to 2035

• The Singapore Healthcare Analytics Market Size Was Estimated at USD 56.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 23.2% from 2025 to 2035
• The Singapore Healthcare Analytics Market Size is Expected to Reach USD 564.5 Million by 2035

According to a research report published by Decisions Advisors, The Singapore Healthcare Analytics Market Size is Anticipated to Reach USD 564.5 Million by 2035, Growing at a CAGR of 23.2% from 2025 to 2035. The market for healthcare analytics in Singapore is mostly driven by expanding use of EHRs and the need for decisions based on data to improve patient outcomes and operational effectiveness in healthcare institutions. In addition, healthcare analytics is established as a vital instrument for stakeholders due to the growing need for cost management and regulatory pushes toward value-based treatment.

Market Overview

Healthcare analytics is the process by which healthcare providers utilise various tools and software to analyse pertinent healthcare data, thereby enhancing patient outcomes, diagnosis, and treatment. Strong expansion as healthcare institutions work to lower costs, increase operational effectiveness, and enhance patient outcomes. An increasing amount of data must be examined in order to derive significant insights due to the expanding use of electronic health records.

Predictive diagnostics is a revolutionary area of AI healthcare that enables proactive rather than reactive patient care. Singapore seeks to decrease the incidence of chronic illnesses, minimize healthcare costs, and enhance long-term health outcomes. In 2024, there will be 180 thousand cases of chronic illness, and the rate of disease progression will drop by 20%.

In March 2022, BC Platforms, a well-known supplier of analytical tools and healthcare data management products, established its research and development facility in Singapore with a focus on Asia Pacific precision medicine. The company has worked with Singapore Health Services (SingHealth), a public health organization. The two organizations would concentrate on creating genetic clinical research procedures under this agreement.

The need for rapid clinical and operational insights, particularly in emergencies and critical care monitoring, is fueled by one trend and a move towards the Real real-time analytics. Another is hyper specialization of analytics, going through the broad platforms to solutions designed for particular medical terms, such as chronic disease modelling, mental health data analysis, and neoplasm informatics.

Report Coverage

This research report categorizes the market for Singapore healthcare analytics market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Singapore healthcare analytics market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Singapore healthcare analytics market.

Driving Factors

The healthcare analytics market in Singapore is driven by the government's innovative ‘Smart Nation’ program, which prioritizes improving public health results and modernizing healthcare facilities. Due to the country's ageing population and rising rates of degenerative diseases, proactive, data-driven healthcare management is required for sustaining the quality of care while lowering costs. The Ministry of Health and a number of associated organizations are actively promoting electronic health records and interoperable data platforms, which have produced sizable, centralized datasets that are prepared for complex analytical treatment. Government subsidies and public-private partnerships make it easier to invest in cutting-edge health data initiatives.

Restraining Factors

The Singaporean healthcare analytics market is restrained by the highly delicate nature of patient information; the primary concern is safeguarding data security and privacy. Strict compliance with local rules, such as the Personal Data Protection Act (PDPA), can result in complex data governance rules that hinder the implementation and incorporation of analytics tools. The shortage of physicians with dual expertise in clinical practice and data science hinders the translation of analytical insights into useful clinical recommendations.

Market Segmentation

The Singapore healthcare analytics market share is classified into type, component, delivery mode, and application.  

• The descriptive analytics segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.   

Based on type, the Singapore healthcare analytics market is segmented into descriptive analytics, diagnostic analytics, predictive analytics, and prescriptive analytics. Among these, the descriptive analytics segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segmental growth is driven by its fundamental role in comprehending historical healthcare performance and trends. Descriptive analytics is a crucial tool for preliminary insights and operational monitoring because healthcare businesses often rely on it for reporting and dashboards to summarize historical data.

• The services segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The Singapore healthcare analytics market is segmented by component into software, hardware, and services. Among these, the services segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is driven by the continuous requirement for complicated healthcare analytics solutions' implementation, customization, maintenance, and consulting support. Service providers will always be in demand due to the specific knowledge needed to implement and maintain these systems.

• The on-premises segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.   

Based on delivery mode, the Singapore healthcare analytics market is segmented into on-premises, web-hosted, and cloud-based. Among these, the on-premises segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segmental growth is driven by improved accessibility from far-flung areas and reduced operating and maintenance expenses. On-premise deployment refers to the installation of systems and solutions on computers within the company. Many software solutions, even though they are installed on-site, can be used remotely for less money and require less upkeep.

• The financial segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The Singapore healthcare analytics market is segmented by application into clinical, financial, operational and administrative. Among these, the financial segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is driven by employed by businesses that use financial data analytics to find inefficiencies, cut back on wasteful spending, and improve their overall financial performance. Financial data analytics is used by major healthcare providers worldwide to enhance billing procedures, lower claim denials, and increase revenue management.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Singapore healthcare analytics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Sopeonow
• Weathervane Pte. Ltd
• Amplify Health
• EVYD Technology
• MiCare HealthTech Holdings
• Analytic Edge
• Cetas Healthcare
• Everlytics Data Science
• Riverr Pte. Ltd
• IQVIA Singapore
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In October 2025, AIA Singapore partnered with health technology firm Amplify Health to launch a Chronic Disease Management Programme (CDMP) aimed at helping Singaporeans manage diabetes, high blood pressure, and high cholesterol.

Market Segment

This study forecasts revenue at the Singapore, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Singapore Healthcare Analytics Market based on the below-mentioned segments:

Singapore Healthcare Analytics Market, By Type

• Descriptive Analytics
• Diagnostic Analytics
• Predictive Analytics
• Prescriptive Analytics

Singapore Healthcare Analytics Market, By Component

• Software
• Hardware
• Services

Singapore Healthcare Analytics Market, By Delivery Mode

• On-Premises
• Web Hosted
• Cloud-Based

Singapore Healthcare Analytics Market, By Application

• Clinical
• Financial
• Operational and Administrative